Lobbying Governance
| Overall Assessment | Analysis | Score |
|---|---|---|
| None |
Ionis Pharmaceuticals has not disclosed any specific governance framework for its lobbying activities. It states that it "established a formal government affairs and public policy function in 2024" and is "committed to transparency" as it "plan[s] to make required lobbying disclosures, trade association memberships and contributions publicly available." However, the company does not disclose any mechanisms for reviewing or managing its lobbying, neither for direct engagement nor through trade associations, nor does it identify a specific individual or formal body that "oversees or reviews" lobbying alignment. We found no evidence of a policy to ensure that its lobbying aligns with its corporate or climate objectives, and there are no oversight or sign-off steps related to lobbying governance disclosed.
View Sources
|
E |